CATALOGO DEI PRODOTTI DELLA RICERCA

MATTE', Alessandro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.186
EU - Europa 1.881
AS - Asia 1.626
SA - Sud America 278
AF - Africa 27
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.007
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.152
GB - Regno Unito 615
CN - Cina 573
SG - Singapore 570
IT - Italia 255
BR - Brasile 241
RU - Federazione Russa 183
HK - Hong Kong 173
SE - Svezia 172
FR - Francia 142
IE - Irlanda 141
DE - Germania 129
VN - Vietnam 119
FI - Finlandia 104
JP - Giappone 41
UA - Ucraina 37
ID - Indonesia 36
KR - Corea 31
AT - Austria 22
NL - Olanda 20
CA - Canada 17
IN - India 17
BE - Belgio 16
AR - Argentina 15
MX - Messico 13
ES - Italia 10
TR - Turchia 9
TW - Taiwan 9
BD - Bangladesh 6
EG - Egitto 6
PL - Polonia 6
AU - Australia 5
EC - Ecuador 5
GR - Grecia 5
IQ - Iraq 5
TG - Togo 5
CZ - Repubblica Ceca 4
KG - Kirghizistan 4
MA - Marocco 4
OM - Oman 4
PK - Pakistan 4
PY - Paraguay 4
UZ - Uzbekistan 4
CH - Svizzera 3
CL - Cile 3
CO - Colombia 3
LT - Lituania 3
NG - Nigeria 3
VE - Venezuela 3
ZA - Sudafrica 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
EU - Europa 2
JO - Giordania 2
KH - Cambogia 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NP - Nepal 2
RO - Romania 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
DK - Danimarca 1
DZ - Algeria 1
GE - Georgia 1
GH - Ghana 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
LB - Libano 1
LI - Liechtenstein 1
LV - Lettonia 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SN - Senegal 1
SV - El Salvador 1
TN - Tunisia 1
VC - Saint Vincent e Grenadine 1
ZW - Zimbabwe 1
Totale 6.007
Salva come PNG Salva come JPEG
Città #
Southend 538
Chandler 340
Singapore 256
Dallas 234
Jacksonville 188
Hong Kong 169
Ann Arbor 154
Dublin 141
Ashburn 125
Verona 114
Beijing 109
Houston 84
Woodbridge 78
Wilmington 69
Dong Ket 57
Lawrence 50
Princeton 50
Jinan 48
New York 44
Los Angeles 39
Nanjing 39
Jakarta 36
Tokyo 35
Helsinki 34
Hebei 32
Shenyang 31
Munich 27
The Dalles 24
Buffalo 22
São Paulo 20
Lancaster 19
Redondo Beach 19
Collegeville 18
Council Bluffs 18
Falls Church 18
Ningbo 18
Columbus 17
Redmond 17
Sindelfingen 17
Brussels 16
Changsha 16
Hangzhou 16
Milan 16
Nanchang 16
Seattle 16
Turku 16
Zhengzhou 16
Vienna 15
Nuremberg 14
Boardman 13
Guangzhou 13
Ho Chi Minh City 12
Taiyuan 12
Tianjin 11
Haikou 10
Jiaxing 10
San Francisco 10
Santa Clara 10
Chicago 9
Taizhou 9
Campinas 8
Frankfurt am Main 8
Montreal 8
Belo Horizonte 7
Bologna 7
Lanzhou 7
London 7
Moscow 7
Redwood City 7
Stockholm 7
Cagliari 6
Cambridge 6
Catanzaro 6
Dongguan 6
Norwalk 6
Cincinnati 5
Fairfield 5
Fuzhou 5
Goiânia 5
Guarulhos 5
Lomé 5
Renton 5
Rome 5
Seoul 5
Tacoma 5
Washington 5
Bishkek 4
Brooklyn 4
Chieti 4
Chions 4
Crotone 4
Porto Alegre 4
Sassari 4
Shanghai 4
Toronto 4
Villiers-sur-marne 4
Warsaw 4
Yangzhou 4
Atlanta 3
Baghdad 3
Totale 3.836
Salva come PNG Salva come JPEG
Nome #
Hypoxia-reperfusion affects osteogenic lineage and promotes sickle cell bone disease 227
Impaired pro‐resolving mechanisms promote abnormal NETosis , fueling autoimmunity in sickle cell disease 179
CD66b-CD64dimCD115- cells in the human bone marrow represent neutrophil-committed progenitors 178
Fyn kinase is a novel modulator of erythropoietin signaling and stress erythropoiesis. 170
TREATMENT OF SKELETAL DISEASES WITH A NATURALLY DERIVED ANTIOXIDANT AND BISPHOSPHONATE EMBEDDED NANOPARTICLES 160
Two-photon microscopy imaging of thy1GFP-M transgenic mice: a novel animal model to investigate brain dendritic cell subsets in vivo 154
Protease inhibitors-based therapy induces acquired spherocytic-like anemia and ineffective erythropoiesis in chronic HCV patients 143
A Selective Oral GLYT1 Inhibitor, Improves Anemia and Red Cell Survival in a Mouse Model of Beta-Thalassemia 142
A new molecular link between defective autophagy and erythroid abnormalities in chorea-acanthocytosis 134
The interplay between peroxiredoxin-2 and Nrf2 is important in limiting oxidative mediated dysfunction in b-thalassemic erythropoiesis 132
Membrane association of peroxiredoxin-2 in red cells is mediated by the N-terminal cytoplasmic domain of band3 129
Oxidative stress and b-thalasssemic erythroid cells behind the molecular defect 126
Band 3 Erythrocyte Membrane Protein Acts as Redox Stress Sensor Leading to Its Phosphorylation by p (72) Syk 125
Integrated proteomic analysis of normal and diseased red cells. Role of physiological stresses in erythrocyte signaling pathways 124
PEROXIREDOXIN-2: A NOVEL REGULATOR OF IRON HOMEOSTASIS IN INEFFECTIVE ERYTHROPOIESIS 123
S-nitrosylation of peroxiredoxin II E promotes peroxynitrite-mediated tyrosine nitration 122
Heat shock protein-27, 70 and peroxiredoxin-II show molecular chaperone function in sickle red cells: evidences from transgenic sickle cell mouse model 122
Erythrocyte membrane changes of chorea-acanthocytosis are the result of altered Lyn kinase activity 118
NCOA4 Deficiency Impairs Systemic Iron Homeostasis 118
Peroxiredoxin-2: A Novel Factor Involved in Iron Homeostasis 118
Therapeutic targeting of Lyn kinase to treat chorea-acanthocytosis 117
Dietary w-3 fatty acids protect against vasculopathy in a transgenic mouse model for sickle cell disease. 116
Resveratrol accelerates erythroid maturation by activation of FoxO3 and ameliorates anemia in beta-thalassemic mice 115
IN ChAc RED CELLS THE ABNORMALLY ACTIVATED LYN AFFECTS ANKYRIN MULTIPROTEIN COMPLEXES AND IS INHIBITED BY DASATINIB 114
Factor H interfers with the adhesion of sickle red cells to vascular endothelium: a novel disease modulating molecule 114
Pharmacological inhibition of calpain-1 prevents red cell dehydration and reduces Gardos channel activity in a mouse model of sickle cell disease 113
New Therapeutic Options for the Treatment of Sickle Cell Disease. 111
Data demonstrating the role of peroxiredoxin 2 as important anti-oxidant system in lung homeostasis. 108
Proteomic analysis of S-nitrosylated proteins in Arabidopsis thaliana undergoing hypersensitive response 107
The novel role of peroxiredoxin-2 in red cell membrane protein homeostasis and senescence. 106
Deoxygenation affects tyrosine phosphoproteome of red cell membrane from patients with sickle cell disease 104
Emerging drugs in randomized controlled trials for sickle cell disease: are we on the brink of a new era in research and treatment? 103
Oxidation and erythropoiesis 102
Oxidized and poorly glycosylated band 3 is selectively phosphorylated by Syk kinase to form large membrane clusters in normal and G6PD-deficient red blood cells 101
Increased levels of ERFE-encoding FAM132B in patients with congenital dyserythropoietic anemia type II 100
Resolution of sickle cell disease-associated inflammation and tissue damage with 17R-resolvin D1. 100
Proteomic and functional analysis of tyrosinephosphorylated red cell membrane proteins in mouse lacking SRC-family-kinases 99
Resolvin D1 and Resolvin D2 Protect Against Hypoxia/Reoxygenation Induced Lung and Kidney Damage in a Sickle Cell Mouse Model of Acute Vaso-Occlusive Crisis 95
Peroxiredoxin-2 (Prx2) expression is increased in beta thalassemic mouse red cells but displaced from the membrane as marker of oxidative stress 94
Peroxiredoxin-2 plays a pivotal role as multimodal cytoprotector in the early phase of pulmonary hypertension 93
Effects of hypoxia–reoxygenation stimuli on renal redox status and nuclear factor erythroid 2-related factor 2 pathway in sickle cell SADmice 92
The Novel Role That Nrf2 Plays in Erythropoiesis during Aging 91
Tyrosine phosphorylation modulates peroxiredoxin-2 activity in normal and diseased red cells 90
Pesticide toxicogenomics across scales: in vitro transcriptome predicts mechanisms and outcomes of exposure in vivo 83
Performance of a novel sieving matrix of Poly(vinyl alcohol)ACRYLAMIDE copolymer in elecrophoretic separations of high molecular weight proteins from red cell membrane. 82
Pathologic angiogenesis in the bone marrow of humanized sickle cell mice is reversible by blood transfusion 82
Fyn specifically Regulates the activity of red cell glucose-6-phosphate-dehydrogenase 79
Red Blood Cell Homeostasis: Pharmacological Interventions to Explore Biochemical, Morphological and Mechanical Properties. 78
Bitopertin, a selective oral GLYT1 inhibitor, improves anemia in a mouse model of β-thalassemia 77
Adaptative Up-Regulation of PRX2 and PRX5 Expression Characterizes Brain from a Mouse Model of Chorea-Acanthocytosis 70
Epeleuton, a novel synthetic ω-3 fatty acid, reduces hypoxia/ reperfusion stress in a mouse model of sickle cell disease 70
Plasma peroxiredoxin changes and inflammatory cytokines support the involvement of neuro-inflammation and oxidative stress in Autism Spectrum Disorder 64
Oxidation Impacts the Intracellular Signaling Machinery in Hematological Disorders 59
An Oral Carbon Monoxide-Releasing Molecule Protects against Acute Hyper-hemolysis in Sickle Cell Disease 56
Mitapivat metabolically reprograms human beta-thalassemic erythroblasts, increasing their responsiveness to oxidation 32
Pharmacological Inhibition of Calpain-1 Prevents Red Cell Dehydration and Reduces Gardos Channel Activity in a Mouse Model of Sickle Cell Disease. Identification of Druggable Protease Target 26
PEROXIREDOXIN-2 (Prx2) MEMBRANE DISPLACEMENT IS A NEW ADDITIONAL FACTOR to the SEVERITY of beta-THALASSEMIC MOUSE RED CELL MEMBRANE DAMAGE 25
Totale 6.112
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.084
article - articoli 18.936
book - libri 0
conference - conferenze 2.790
curatela - curatele 0
other - altro 358
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.168
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021350 0 0 0 49 43 44 17 14 13 7 54 109
2021/2022444 32 130 14 34 21 11 14 25 35 17 18 93
2022/2023983 62 132 82 150 90 240 8 37 98 33 32 19
2023/2024536 22 40 39 61 66 78 25 35 9 14 109 38
2024/20251.426 76 64 49 242 77 96 129 69 209 81 100 234
2025/2026718 264 176 246 32 0 0 0 0 0 0 0 0
Totale 6.112